ESR1 and breast neoplasm: AURKA promotes epithelial-mesenchymal transition and stem cell properties of ER + breast tumors in a mechanism involving overexpression of HER2 [39], while PAK1 is an essential mediator of HER2 signaling in mammary tumors dependent on this protein [13].